| THURSDAY JUNE 2 |
|
|
| 0800-0805 |
Welcome and Introductory Remarks
B. Gilks and E. Torlakovic
|
| |
|
| 0805-0850 |
Antibody Validation: The Good, The Bad and The Ugly
A. Gown
|
| |
|
| 0850-0920 |
Recent developments in IHC for lymphoma diagnosis and classification
R. Gascoyne
|
| |
|
| 0920-1000 |
The role of IHC in the Diagnosis of Mesothelioma (with CIQC Run 16 follow-up)
A. Churg
|
| |
|
| 1000-1030 |
IHC for lung cancer subtype diagnosis
D. Ionescu
|
| |
|
| 1030-1040 |
Break
|
| |
|
| 1040-1140 |
IHC - the technical and diagnostic challenge - from fixation to interpretation
S. Nielsen
|
| |
|
| 1140-1200 |
Ask the experts - submit questions for discussion by our expert panel
|
| |
|
| 1200-1300 |
Lunch
|
| |
|
| 1300-1415 |
External Quality Assessment in Diagnostic Immunohistochemistry, an update
M. Vyberg
|
| |
|
| 1415-1515 |
Mismatch Repair Enzyme Immunohistochemistry: interpretation, reporting and ethical issues
A. Pollett and B. Clarke
|
| |
|
| 1515-1530 |
Break
|
| |
|
| 1530-1600 |
cIQc update
J. Garratt and B. Gilks
|
| |
|
| 1600-1700 |
New Breast Cancer Biomarkers (Ki67 and basal-like markers)
T. Nielsen and J. Choo
|
| |
|
| 1700 |
Adjourn
|
| |
|
| FRIDAY JUNE 3 |
|
|
| 0800-1200 |
IHC Workshop. Identification of the Unknown Primary
E. Torlakovic, M. Vyberg and M. Hayes
|
| |
|
| 1200-1300 |
Lunch
|
| |
|
1300-1700: Molecular Pathology in Personalized Medicine
M. Tsao and D. Lebrun (moderators)
|
| |
|
| 1300-1310 |
Introductory Remarks
D. Lebrun
|
| |
|
| 1310-1350 |
Personalized Medicine – Role of molecular biomarkers
M. Tsao
|
| |
|
| 1350-1410 |
Sequencing platforms – mutation and single nucleotide polymorphism
S. Kamel-Reid
|
| |
|
| 1410-1430 |
Gene copy number analysis – FISH/CISH/SISH
TBD
|
| |
|
| 1430-1450 |
Sample processing for molecular studies
G. Turashvili
|
| |
|
| 1450-1500 |
Discussion
|
| |
|
| 1500-1515 |
Break
|
| |
|
| 1515-1540 |
miRNAs in diagnostic pathology
V. Tron
|
| |
|
| 1540-1600 |
HER2 in gastric cancer
D. Huntsman
|
| |
|
| 1600-1630 |
Integrative genomic pathology – Molecular pathology of the future
W. Lam
|
| |
|
| 1630-1655 |
New biomarker analysis platforms on the horizon
T. Magliocco
|
| |
|
| 1655-1700 |
Closing remarks
M. Tsao
|
| |
|
N.B. The Molecular Pathology symposium is new this year and will complement the IHC workshop that is now in its third year.
|
| |
|
| |
|
| |
|
| |
|
